| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.33T+9.3% | $293.96T+12.1% | $262.17T+9.9% | $238.59T+11.5% | $213.99T+12.7% | $189.89T+5.7% | $179.59T+6.9% | $167.94T+9.7% | $153.14T |
| Cost of goods sold | $309.85T+9.1% | $284.05T+12.2% | $253.21T+10.0% | $230.29T+11.2% | $207.05T+12.1% | $184.70T+5.9% | $174.45T+6.8% | $163.33T+9.9% | $148.60T |
| Gross profit | $11.48T+15.8% | $9.91T+10.6% | $8.96T+8.0% | $8.30T+19.5% | $6.94T+33.7% | $5.19T+1.0% | $5.14T+11.4% | $4.61T+1.5% | $4.55T |
| Distribution, selling, and administrative | $6.49T+14.7% | $5.66T+6.6% | $5.31T+9.5% | $4.85T+34.9% | $3.59T+29.9% | $2.77T+3.9% | $2.66T+8.3% | $2.46T+15.6% | $2.13T |
| Depreciation | $494.14B+15.3% | $428.50B+4.4% | $410.34B+6.1% | $386.60B+18.3% | $326.82B+16.6% | $280.19B-5.0% | $294.96B+3.9% | $283.97B+19.8% | $237.10B |
| Amortization | $556.93B-16.1% | $663.47B+19.9% | $553.56B+80.1% | $307.30B+72.3% | $178.35B+60.9% | $110.88B-33.8% | $167.44B-7.6% | $181.16B+12.9% | $160.50B |
| Litigation and opioid-related expenses (credit), net | $60.67B-73.3% | $227.07B+1019.6% | -$24.69B-120.0% | $123.19B-54.8% | $272.62B-95.9% | $6.72T | — | — | — |
| Acquisition-related deal and integration expenses | $291.04B+182.6% | $103.00B-26.3% | $139.68B+16.8% | $119.56B+2.2% | $116.97B | — | — | — | — |
| Restructuring and other expenses | $229.42B-1.8% | $233.63B+1.6% | $229.88B+262.0% | $63.50B-22.9% | $82.32B | — | $330.47B+80.1% | $183.52B-80.9% | $959.33B |
| Goodwill impairment | $723.88B+73.2% | $418.00B | $0-100.0% | $75.94B+1091.5% | $6.37B | $0 | $0-100.0% | $59.68B | $0 |
| Operating income | $2.63T+20.8% | $2.18T-7.1% | $2.34T-1.1% | $2.37T+0.5% | $2.35T+145.8% | -$5.14T-561.8% | $1.11T-23.0% | $1.44T+36.2% | $1.06T |
| Other loss (income), net | $78.72B+451.1% | $14.28B+129.1% | -$49.04B-79.3% | -$27.35B+34.5% | -$41.74B-2539.8% | -$1.58B+87.8% | -$12.95B-150.9% | $25.47B+1032.9% | -$2.73B |
| Interest expense, net | $291.55B+85.7% | $156.99B-31.4% | $228.93B+8.7% | $210.67B+21.0% | $174.07B+26.2% | $137.88B-12.6% | $157.77B-9.7% | $174.70B+20.3% | $145.19B |
| Income before income taxes | $2.26T+12.7% | $2.00T-7.3% | $2.16T-1.0% | $2.18T-1.7% | $2.22T+142.0% | -$5.29T-647.4% | $967.11B | — | $917.89B |
| Income tax expense | $690.52B+42.5% | $484.70B+13.2% | $428.26B-17.1% | $516.52B-23.7% | $677.25B+135.8% | -$1.89T-1776.8% | $112.97B+125.8% | -$438.47B-179.2% | $553.40B |
| Net income | $1.57T+3.2% | $1.52T-12.3% | $1.73T+4.0% | $1.67T+7.9% | $1.54T+145.4% | -$3.40T-498.0% | $854.13B-47.1% | $1.62T+343.3% | $364.48B |
| Net (income) loss attributable to noncontrolling interests | -$13.64B-34.4% | -$10.15B-179.8% | $12.72B-60.6% | $32.28B+790.3% | -$4.68B+48.9% | -$9.16B-844.6% | $1.23B-97.1% | $42.51B | $0 |
| Net income attributable to Cencora, Inc. | $1.55T+3.0% | $1.51T-13.5% | $1.75T+2.7% | $1.70T+10.3% | $1.54T+145.2% | -$3.41T-498.5% | $855.37B-48.4% | $1.66T+355.0% | $364.48B |
| Basic (in usd per share) | $8020.00+5.5% | $7600.00-11.8% | $8620.00+5.8% | $8150.00+9.0% | $7480.00+45024.9% | -$16.65-509.1% | $4.07-46.5% | $7.61+355.7% | $1.67 |
| Diluted (in usd per share) | $7960.00+5.7% | $7530.00-11.7% | $8530.00+6.1% | $8040.00+8.8% | $7390.00+44484.4% | -$16.65-512.1% | $4.04-46.3% | $7.53+359.1% | $1.64 |
| Basic (in shares) | 193.8M-2.4% | 198.5M-2.0% | 202.5M-2.9% | 208.5M+1.2% | 205.9M+0.6% | 204.8M-2.6% | 210.2M-3.5% | 217.9M-0.2% | 218.4M |
| Diluted (in shares) | 195.2M-2.5% | 200.3M-2.1% | 204.6M-3.1% | 211.2M+1.3% | 208.5M+1.8% | 204.8M-3.3% | 211.8M-3.9% | 220.3M-0.6% | 221.6M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.